Originally published In Press as doi:10.1074/jbc.M001168200 on May 12, 2000
J. Biol. Chem., Vol. 275, Issue 32, 24333-24340, August 11, 2000
Molecular Cloning and Expression of Mammalian Peroxisomal
trans-2-Enoyl-coenzyme A Reductase cDNAs*
Arun K.
Das,
Michael D.
Uhler, and
Amiya K.
Hajra
From the Mental Health Research Institute and Department of
Biological Chemistry, University of Michigan,
Ann Arbor, Michigan 48104-1687
Received for publication, February 10, 2000, and in revised form, April 20, 2000
 |
ABSTRACT |
Chain elongation of fatty acids is an important
cellular process and is believed to occur in the endoplasmic reticulum
of all eukaroytic cells. Herein we describe the cloning and
characterization of a peroxisomal NADPH-specific
trans-2-enoyl-CoA reductase, the key enzyme for a proposed
peroxisomal chain elongation pathway. The reductase was solubilized and
partially purified from guinea pig liver peroxisomes by affinity
chromatography. On SDS-polyacrylamide gel electrophoresis, a 40-kDa
band was identified as the enzyme, and its partial amino acid sequence
(27 amino acids) was determined. A full-length cDNA for the
reductase was cloned from a guinea pig liver cDNA library. The open
reading frame of this nucleotide sequence encodes a 302-amino acid
polypeptide with a calculated molecular mass of 32.5 kDa. Full-length
mouse and human cDNA clones encoding homologous proteins have also
been isolated. All of these translated polypeptides have the type I
peroxisomal targeting signal, AKL, at the carboxyl terminus. The
identity of the cloned enoyl-CoA reductase cDNAs was confirmed by
expressing the guinea pig and human cDNAs in Escherichia
coli. The His-tagged recombinant enzymes were found to have very
high NADPH-specific 2-enoyl-CoA reductase activity with similar
properties and specificity as the liver peroxisomal reductase. Both the
natural and the recombinant enzyme catalyze the reduction of
trans-2-enoyl-CoAs of varying chain lengths from 6:1 to
16:1, having maximum activity with 10:1 CoA. Northern blot analysis
demonstrated that a single transcript of 1.3 kilobases is
present in most mouse tissues, with particularly high concentrations in
liver and kidney.
 |
INTRODUCTION |
In mammalian cells, the fatty acid chain elongation system has
been shown to be present in both endoplasmic reticulum
(ER)1 and mitochondria (1).
The ER pathway is similar to the fatty acid synthesis system. In this
multistep process, malonyl-CoA first condenses with acyl-CoA to form a
-keto acyl-CoA with two additional carbons with the release of
CO2. The
-keto acyl-CoA then undergoes reduction of the
ketone group followed by dehydration to form a 2-enoyl-CoA, which is
then reduced by NADH or NADPH to form the longer (+2C) acyl-CoA. Chain
elongation and other biotransformation of fatty acids have been shown
to occur primarily in the ER (1, 2). The mitochondrial chain elongation
system is a reversal of the fatty acid
-oxidation system; thus,
acetyl-CoA, instead of malonyl-CoA, is used for the condensation
reaction, and the resulting
-keto acyl-CoA undergoes the same series
of reactions as described above (3). The physiological function of the
mitochondrial chain elongation system is not clear (4).
Contradictory findings have been reported regarding the presence of
another cellular fatty acid chain elongation system in mammalian
peroxisomes. Nagi et al. (5) initially reported the absence
of an elongation system in rat liver peroxisomes. However, Horie
et al. (6) later provided good evidence for the presence of
an active peroxisomal chain elongation system in rat liver. This
peroxisomal system was shown to be similar to the mitochondrial system
in that acetyl-CoA is used as the carbon donor for chain elongation. In
both, all of the chain elongation reactions are apparently catalyzed by
the fatty acid
-oxidation pathway enzymes in the reverse directions
except for the last step (i.e. the reduction of the
2-enoyl-CoA). This is because in the
-oxidation pathway the initial
oxidation of acyl-CoAs to 2-enoyl-CoAs is an irreversible step
catalyzed by either acyl-CoA dehydrogenase (mitochondria) or oxidase
(peroxisomes). Therefore, a separate 2-enoyl-CoA reductase is necessary
for the reduction of the double bond at C-2 at the last step of
elongation. Mitochondria have been shown to contain such a specific
2-enoyl-CoA reductase, which has been purified to homogeneity as a
35.5-kDa protein (4). This purified enzyme only utilized NADPH as the
coenzyme. Horie et al. (6) provided good evidence for the
presence of a similar NADPH-linked enoyl-CoA reductase in rat liver
peroxisomes, although the enzyme was not solubilized or purified.
During the course of purification of guinea pig liver peroxisomal
acyldihydroxyacetone phosphate (DHAP) reductase (7), a contaminating
40-kDa protein was found to be associated with the reductase. This
protein was found to bind to the NADPH affinity column along with the
acyl-DHAP reductase. We report here that this protein is a 2-enoyl-CoA
reductase. From its partial amino acid sequence information, we have
cloned the cDNA of this guinea pig liver protein and also the
corresponding mouse and human cDNAs. The guinea pig cDNA was
expressed in Escherichia coli, and the recombinant protein
has been found to have high trans-2-enoyl-CoA reductase
activity with NADPH as the reductant.
 |
EXPERIMENTAL PROCEDURES |
Synthesis of trans-2-Enoyl-CoAs--
trans-2-Hexenoic
and octenoic acids were obtained from Aldrich.
trans-2-Decenoic, 2-dodecenoic, and 2-hexadecenoic acids
were kind gifts from Dr. Shuichi Horie (Teikyo University, Kanagawa, Japan). trans-2-Tetradecenoic acid was synthesized by
condensing dodecyl aldehyde (Aldrich) with malonic acid in pyridine
followed by decarboxylation as described by Lauer et al.
(8). All-trans-2,4-decadienoic acid was prepared by
oxidizing 2-trans,4-trans-decadienal (Aldrich) by
Ag2O as described (9). The CoA derivatives of all these fatty acids were prepared by first converting them to acyl chlorides, followed by condensing the acyl chlorides with CoASH (1.1:1.0 molar
ratio) in carbonate buffer at pH 8.5 as described previously (10). The
12:1, 14:1, and 16:1 CoA were purified by perchloric acid precipitation
followed by acetone and ether washings (10). The crude 6:1, 8:1, and
10:1 CoA preparations were purified by acidification to pH 3 followed
by extraction with diethyl ether to remove the free fatty acids. The pH
of the aqueous layers was then adjusted to 6.0, and the enoyl-CoA was
lyophilized. The 10:1 CoA was further purified by hydrophobic
chromatography on an octadecyl-silica column. The decenoyl-CoA
dissolved in 0.1 M sodium phosphate buffer (pH 6.0) was
loaded onto a 2-ml C-18 SPE-Bakerbond cartridge (J.T. Baker), and after
washing the column with 8 ml of the same buffer, the enoyl-CoA was
eluted with 4 ml of methanol. The methanol was removed at room
temperature by blowing a stream of N2, and the residue was
dissolved in 0.05 M sodium phosphate buffer (pH 6.0). The
recovery of the enoyl-CoA was 80%. Thin-layer chromatography of the
acyl-CoAs on Silica Gel 60 (Merck) using butanol/acetic acid/water
(50:20:30) as the mobile phase (10) showed that the acyl-CoAs
(Rf = 0.45) were pure, with only traces of free CoA
(Rf = 0.16) and no free fatty acids
(Rf = 0.82) present as contaminant. The enoyl-CoAs
were also characterized by their spectral properties (10, 11).
Crotonyl-(trans-4:1
2)-CoA was purchased from
Sigma. The concentrations of the acyl-CoAs were determined by measuring
the amount of CoASH released after alkaline hydrolysis, with
5,5'-dithio-bis(2-nitrobenzoic acid) (12).
Assay of Enoyl-CoA Reductase--
Spectrophotometric and
radiometric assays were used to measure the enzyme activity. In the
radiometric assay, the incubation mixture contained phosphate buffer
(50 mM, pH 7.4),
S-[4-3H]NADPH (70 µM,
8000 dpm/nmol), fatty acid-poor bovine serum albumin (2 mg/ml),
enoyl-CoAs (30-40 µM), and enzyme protein in a total volume of 0.3 ml. After incubation at 37 °C for 5 min, the reactions were stopped by adding 50 µl of 1 N NaOH. The mixture was
incubated at 37 °C for an additional 10 min to hydrolyze all
acyl-CoAs and then acidified by adding 10 µl of 6 N HCl
followed by the addition of 0.75 ml of 2 M KCl containing
0.05 M H3PO4. The free fatty acids
were extracted from the mixture with 1 ml of toluene, and the
3H radioactivity in an aliquot of the toluene layer was
determined by liquid scintillation spectrometry.
For the spectrophotometric assay, the incubation mixture was the same
as above except that nonradioactive NADPH (0.l mM) was used
instead of the [3H]NADPH. The time course of oxidation of
NADPH was monitored at 340 nm using a Beckman DU70 spectrophotometer.
Controls containing all ingredients except the enoyl-CoAs were always
run in parallel, and the control values were subtracted from the
experimental ones.
2,4-dienoyl-CoA reductase activity was measured radiometrically as
described by Nada et al. (13).
Purification of Enoyl-CoA Reductase from Peroxisomes--
Guinea
pig liver peroxisomes, isolated as described (14), were suspended in
0.25 M sucrose, 10 mM TES, 1 mM
EDTA buffer (pH 7.5) containing 0.1% Triton X-100 and protease
inhibitors (1 µM leupeptin, 0.2 mM
phenylmethylsulfonyl fluoride). The mixture was stirred for 30 min at
room temperature and then centrifuged at 100,000 × g
for 40 min. The enzyme from the pellet was solubilized in the above
buffer containing also 1.0 M KCl and 0.3 mM
NADPH. The mixture was centrifuged as above, and the supernatant was dialyzed overnight against a buffer (pH 7.4) containing 10 mM Tris, 2 mM dithiothreitol, 20% glycerol,
0.05% Triton X-100, and 0.2 M KCl. The dialyzed sample was
centrifuged at 100,000 × g for 40 min to remove the
precipitated acyl-DHAP reductase (7), and the supernatant was loaded
onto a 2-ml agarose gel column containing bound NADP+ (4-5
µmol/ml) prepared as described previously (7). The column was washed
with 12 ml (six fractions of 2 ml each) of the above dialyzing buffer,
and then the enzyme was eluted from the column by using 12 ml (in 2-ml
fractions) of the same buffer but also containing NADPH (2 mM).
SDS-PAGE Analysis--
SDS-PAGE and staining of the gel with
Coomassie Blue G250 were as described before (15). Proteins from dilute
samples were concentrated by trichloroacetic acid coprecipitation with
carrier sodium deoxycholate (16) before electrophoresis. The
precipitates were washed once with acetone to remove the trichloracetic
acid, dissolved in 15 µl of sample buffer (0.1 M
Tris-HCl, pH 6.8, 2% SDS, 20%
-mercaptoethanol, 10% glycerol, and
0.02% bromphenol blue) by heating at 100 °C, and loaded on the gel.
Characterization of the Reaction Product by Argentation-Thin
Layer Chromatography--
The AgNO3-containing thin layer
chromatography plates were prepared by dipping the plates (Silica Gel
60; Merck) in a 30% AgNO3 solution in acetonitrile. After
air-drying, the plates were activated by heating in an oven at
110 °C for 1 h, cooled, and used immediately. The
3H-labeled product formed by incubating 10:1 CoA and
S-[4-3H]NADPH with the enzyme was converted to
free fatty acids by hydrolysis as described above for the radiometric
assay method. Fifty µg each of decanoic acid and
trans-2-decenoic acid were added to the toluene extracts
containing the labeled free acids, and the toluene was removed by
blowing nitrogen. The fatty acids were converted to the methyl esters
by treatment with 2,2'-dimethoxypropane-methanol-HCl as described
previously (17). The methyl esters, along with the methyl ester
standards were spotted on the AgNO3-impregnated plate, and
the plate was developed with hexane/diethyl ether/acetic acid
(70:30:1). In this system, the methyl ester of the
trans-2-enoic fatty acids migrates at a slower rate
(Rf = 0.56) than the corresponding methyl esters of
saturated fatty acids (Rf = 0.64), as also described
by Wood and Lee (18). The methyl ester spots on the TLC plate were
visualized under UV light after spraying with Primuline (19) and
scraped out, and the esters were extracted by chloroform-methanol (1:1)
followed by removal of the solvents by blowing air. The amount of
3H in the extracts was quantified by liquid
scintillation spectrometry.
Partial Amino Acid Sequencing--
Amino acid sequencing by
Edman degradation was performed at the Protein Sequencing Facility of
the University of Michigan. The partially purified enzyme was subjected
to SDS-PAGE, the gel area corresponding to the 40-kDa band was excised
and treated with CNBr (20), and the cleavage products were separated by SDS-PAGE followed by blotting on to a polyvinylidine difluoride membrane (Problott; Applied Biosystems). Two peptide bands from the
blot, 3 and 6 kDa in size, were used directly for amino acid sequencing
using an Applied Biosystems gas phase sequenator.
Screening Guinea Pig and Mouse Liver cDNA
Libraries--
Total RNA from tissues was isolated by using an acidic
CHCl3-phenol extraction method using the Trizol reagent
(Life Technologies, Inc.) following the manufacturer's protocol and
then further purified by CsCl density gradient centrifugation (21). A
guinea pig liver cDNA library in Zap Express vector was made by
Stratagene from the total RNA isolated from livers of adult animals. An
adult mouse liver cDNA library cloned into
ZapII vector was
purchased from Stratagene. The cDNA library screenings were done as
described before (22). The filter paper blots of the colonies were
hybridized with a mouse enoyl-CoA reductase cDNA probe labeled by
using the random decamer priming method (Decaprime II; Ambion) and
[
-32P]dATP. The template DNA used for making the
32P-probe was a 424-base pair (
45 to +378) mouse
enoyl-CoA reductase cDNA fragment prepared by digestion of the
plasmid isolated from a mouse EST clone (AA241896 Genome Systems) with
EcoRI and SphI.
Expression and Purification of the Recombinant Proteins--
A
DNA fragment containing the open reading frame of the guinea pig liver
reductase cDNA in
Zap Express vector (clone 14) was excised by
digestion with EcoRI and XhoI, purified by
agarose gel electrophoresis (1.2-kb fragment), and then ligated into
EcoRI- and XhoI-digested linearized 5.3-kb PET
28a(+) vector (Novagen) using T4 DNA ligase (Promega) in the presence
of ATP. The resulting plasmid encodes a protein in which an
amino-terminal His tag from the vector is fused in frame to the
enoyl-CoA reductase coding sequence. The plasmid was introduced into
competent BL-21 cells by heat-shock treatment according to the
manufacturer's (Promega) instructions, and the transformed cells were
selected for by utilizing their resistance to Kanamycin. The
plasmid-containing bacteria were grown in LB broth with Kanamycin (40 µg/ml) at 37 °C to the mid-log phase (A600 = 0.3-0.4), IPTG (final concentration 0.5 mM) was then
added, and the cells were allowed to grow for another 4-5 h. The cells
were harvested by centrifugation and then lysed by treating with
lysozyme (0.1 mg/ml) at pH 8.0 (50 mM Tris-HCl) in the
presence of 0.1% Triton X-100 for 20 min at 30 °C. The mixture,
cooled in ice, was sonicated two times for 10 s each using a probe
sonicator (Branson). The sonicated mixture was centrifuged at
12,000 × g for 10 min, and the supernatant was
collected. This supernatant was used both to measure the reductase
activity and for the affinity purification of the recombinant
His-tagged enzyme.
For the affinity purification of the recombinant enzyme, the
bacterial extract (5-10 ml) in 20 mM Tris buffer (pH 8.0),
0.5 M NaCl, 5 mM imidazole, and 1.0 mM
-mercaptoethanol (1.0 mM) was loaded onto
a 2.5-ml Ni2+-nitrilotriacetic acid-agarose (Qiagen)
column. The column was washed first with 10 volumes of the above
binding buffer (wash 1) and further washed (wash 2) with six volumes of
the same buffer but containing a higher concentration of imidazole (60 mM). The enzyme was eluted with six volumes of the buffer
containing 0.3 M imidazole (elute 1), followed by elution
with four volumes of 1.0 M imidazole (elute 2).
Raising Monoclonal Antibodies against the
Reductase--
Monoclonal antibodies against the enoyl-CoA reductase
were produced by the Hybridoma Core Facility (University of Michigan). The Balb/c mice were immunized against the partially purified enoyl-CoA
reductase (see above), and their splenic cells were used to generate
the hybridomas. The hybridomas were screened for antibody secretion by
employing a dot blot enzyme-linked immunosorbent assay using the
partially purified enzyme as the antigen. On that basis, six clones
were selected and propagated as ascites cells in mice. One of the
ascites fluid samples (isotype IgG1), which showed high specificity
toward the enoyl-CoA reductase, was used in the Western blot analysis.
Western Blot Analysis of the Subcellular
Fractions--
Subcellular fractionation of guinea pig liver to
isolate major cellular organelles including peroxisomes and the assay
of marker enzymes were done as described previously (14). The Western blot analysis was done by subjecting the subcellular fractions to
SDS-PAGE (15), transferring the separated proteins to a polyvinylidene difluoride membrane, probing the blot with the monoclonal antibody, and
then detecting the antibody-reacting protein bands using the Protoblot
Western blot alkaline phosphatase system kit (Promega).
Northern Blotting--
Total RNA from guinea pig tissues was
isolated and subjected to formaldehyde gel electrophoretic separation
and transfer to Nytran membranes as described (21, 22). The mouse
multiple tissue mRNA blot was from CLONTECH.
The blots were hybridized with the radioactive mouse reductase cDNA
probe prepared as described above. Blots were prehybridized for 30 min
at 68 °C in Express Hyb (CLONTECH) and then
hybridized for 60 min at 68 °C in Express Hyb containing the labeled
probe (3-4 × 106 cpm/ml, 1-2 × 109 cpm/µg of template). The blots were washed three
times at room temperature with a solution containing 2× SSC and 0.05%
SDS, followed by two washes with 0.1× SSC and 0.1% SDS at 50 °C.
The radioactivity on the blots was detected by autoradiography using
Kodak X-Omat AR films.
All other materials and methods were the same as described previously
(7, 22).
 |
RESULTS |
Assay of Enoyl-CoA Reductase--
Both spectrophotometric and
radiometric methods were employed to assay the reductase. The enzyme
activity was stimulated by the presence of bovine serum albumin in the
incubation mixture (Table I). Table I
also shows that NADPH cannot be replaced by NADH as a coenzyme. The
product of the enzymatic reaction was identified as a saturated fatty
acyl-CoA (see below). Although these two assay methods were
qualitatively similar, lower activity (~50%) was seen with the
radiometric assay (Table I), indicating an isotope effect when
3H-labeled NADPH was used as the reductant. However,
because of high sensitivity and ease of assay, the radiometric method
was employed when a large number of samples were to be assayed. The assay method used in other experiments is indicated in the legends of
the figures and tables.
View this table:
[in this window]
[in a new window]
|
Table I
Comparison of assay systems
The incubation mixtures contained potassium phosphate buffer (50 mM), bovine serum albumin (2 mg/ml), either
S-[4-3H]NADPH (70 µM) or NADPH (0.1 mM), guinea pig liver peroxisomes (10-40 µg of protein),
and trans-2-enoyl CoA (30 µM) as indicated
below. Concentration of NADH, when used, was 0.1 mM. The
incubations and assays were done as described. The average
(n = 3 or 4) specific activities along with their S.D.
values are shown.
|
|
Partial Purification of the Peroxisomal Enzyme--
The enzyme
is apparently bound to the peroxisomal membrane, because after osmotic
shock of peroxisomes the enzyme activity remained associated with the
membrane fraction (data not shown). A neutral detergent such as Triton
X-100 in the presence of high concentrations of KCl or NaCl completely
solubilized the enzyme. The enzyme, unlike acyl-DHAP reductase (7),
remained soluble after the salt is dialyzed out. This solubilized
enzyme was further purified by NADP affinity chromatography (Table
II). When analyzed by SDS-PAGE, a 40-kDa
protein band was found to be co-purified with the enzyme activity. This
band was estimated to correspond to 40-60% of total proteins in
different preparations. A typical SDS-PAGE analysis is shown in Fig.
1. Another major protein (60 kDa) that
also binds to the affinity column, seen on the electrophoretogram (Fig.
1), was identified as catalase. Catalase has been shown to contain
bound NADPH, although the physiological significance of the bound NADPH
is unknown (23). The affinity-purified enzyme rapidly lost its activity
upon storage, and attempts to further purify it were not
successful.

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 1.
SDS-PAGE of different fractions obtained
during NADP affinity purification of the reductase. One to 5 µg
of protein (except for lane 4, where 0.15 µg of
protein was used) concentrated (see "Experimental
Procedures") from the indicated column fractions (100-200
µl) were subjected to electrophoretic separation followed by
Coomassie Blue staining. Lane 1, flow-through
(200 µl); lane 2, first 2-ml wash (200 µl);
lane 3, last 2-ml wash (200 µl);
lane 4, 10 µl (without concentration) of the
first 2 ml of the NADPH-eluted fraction; lane 5,
same as lane 4, but 100 µl of the fraction
(after concentration) was used; lanes 6-8, 200 µl each of the next three NADPH-eluted fractions. Lane
9, 0.5 µg of bovine serum albumin (66.2 kDa).
Lane 10, protein molecular weight standards as
shown. The arrowhead shows the 40-kDa band whose partial
amino acid sequence was determined.
|
|
Partial Amino Acid Sequence of the 40-kDa Protein--
The
40-kDa protein band was resistant to Edman degradation, indicating that
N-terminal amino acid of the protein is probably blocked. Therefore,
after SDS-PAGE the protein band was treated with CNBr, and the
resulting peptides were separated by another SDS-PAGE and blotted to a
polyvinylidene difluoride membrane. The main bands on the blot were
then subjected to Edman degradation. A 3-kDa fragment yielded the
longest sequence (27 amino acids) as follows: KSTLALYGKIDFLVNNGGGQFWSSPEH.
Analysis of another fragment (6 kDa) yielded essentially the same
partial amino acid sequence.
Cloning the cDNA of the Reductase--
Upon searching the
GenBankTM data base, a number of human and mouse EST clones
were identified whose DNA sequences coded (80-90% identity) for the
above partial amino acid sequence. One of these mouse EST clones
(AA241896) was used to generate a probe for screening a guinea pig
liver cDNA library. A nucleotide sequence at the 5'-end of the
clone, when translated, showed high (90%) amino acid identity with the
first 21 residues of the guinea pig reductase partial amino acid
sequence we determined. A 0.4-kb fragment containing this stretch of
nucleotides was isolated and used as the template to generate
32P-labeled probe, which was then used to screen the
library. A large number of positive clones were isolated in the screen,
and the plasmids from two of these (clones 9 and 14) that
contained the longest inserts (~1.4 kb) were subjected to nucleotide
sequencing. Both of the strands of each insert were sequenced by the
"primer-walking" method. The sequences obtained were identical
except that the insert from clone 9 was missing 9 base pairs from the
5'-end compared with clone 14. The complete sequence (1380 base pairs)
of clone 14 is shown in Fig. 2. An open
reading frame was identified that started at ATG (+5) within the
consensus Kozak (24) translation initiation sequence (GCCATGG) and
coded for a polypeptide of 302 amino acids, which contained the same 27 amino acid sequence shown to be present in the peroxisomal 40-kDa
protein (Fig. 2). The carboxyl-terminal tripeptide sequence (AKL) is a
type 1 peroxisome-targeting signal (PTS-1) (25). The 0.5-kb
3'-untranslated region contained a noncanonical polyadenylation signal
(AGTAAA) near the poly(A) tail (Fig. 2).

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 2.
Nucleotide and deduced amino acid sequence of
guinea pig liver cDNA encoding peroxisomal enoyl-CoA
reductase. The underlined region corresponds to the
determined partial amino acid sequence of the purified peroxisomal
enzyme. The PTS-1 signal is boxed, and the subscript
asterisks show the putative N-glycosylation signals.
The polyadenylation signal is double
underlined.
|
|
Cloning of the Mouse and Human cDNAs--
A similar
screening of a mouse liver cDNA library using the same probe
yielded a number of positive clones from which a homologous mouse
cDNA sequence was assembled (GenbankTM accession no.
AF232011). By analyzing a number of human EST clones that showed
homology to the mouse and guinea pig cDNAs, we have identified a
clone (AA232159) containing the full-length (1.9-kb) human reductase
cDNA. This human cDNA sequence has also been submitted to the
GenbankTM data base (accession no. AF232009). The three
cDNA sequences have 3'-untranslated regions of varying chain
lengths (0.3 kb for mouse, 0.5 kb for guinea pig, and 0.7 kb for human
cDNAs), which do not show close homology with each other.
Translation of the putative open reading frames of these cDNAs
shows that these polypeptides are highly homologous (71-75% identical
and 90-93% similar) (Fig. 3), the
guinea pig open reading frame being one amino acid shorter than the
other two (303 amino acids). The calculated molecular masses of
the guinea pig, mouse and human reductases are 32.5, 32.3, and 32.6 kDa, respectively. All of them have the PTS-1, AKL, at the carboxyl
end. GenbankTM searches showed that these amino acid
sequences are homologous to a large number of eukaryotic and
prokaryotic pyridine nucleotide-linked dehydrogenases (see
"Discussion").

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 3.
Comparison of the deduced amino acid
sequences of peroxisomal enoyl-CoA reductase from guinea pig, mouse,
rat, and human.
|
|
Fig. 3 also shows the comparison of a putative amino acid sequence of a
rat cDNA sequence that is highly homologous to the enoyl-CoA
reductase protein sequences in other species, especially mouse (86%
identical, 97% similar). This sequence has been submitted to
GenBankTM with a tentative identification as either
short chain acyl dehydrogenase (AF099742) or peroxisomal
2,4-dienoyl-CoA reductase (AF021854). The main difference between the
rat protein and that of the other species is that ARL is the
carboxyl-terminal tripeptide sequence for the rat protein instead of
AKL for the other three. ARL is not a common mammalian PTS-1, but it is
known to be a PTS-1 for S. cerevisiae proteins (25).
Expression and Purification of the Active Recombinant
2-Enoyl-CoA Reductase--
The full-length guinea pig liver cDNA
was subcloned into a T7lac promoter-containing expression vector (Pet
28a), which was then used to transform E. coli cells as
described under "Experimental Procedures." The transformed cells
expressed a protein having high 2-enoyl-CoA reductase activity when the
T7lac inducer IPTG was added to the growing transformed cells in
culture (data not shown). As expected, the recombinant fusion protein,
containing six consecutive His residues at the N terminus, binds
tightly to a Ni2+-chelate affinity resin and can be
quantitatively eluted by imidazole-containing buffer (Fig.
4A). The recombinant
reductase, purified 50-fold from the crude extract, had a specific
activity of 1700 nmol/min/mg of protein (spectrophotometric assay).
Upon SDS-PAGE, the purified enzyme showed a single 43-kDa band (Fig.
4B). The calculated molecular mass of the recombinant
reductase is, however, 36.7 kDa. The purified enzyme is unstable toward
storage at 4 °C or
70 °C but is somewhat stabilized by thiols
such as
-mercaptoethanol or dithiothreitol. The half-life of the
enzyme in the presence of 1 mM dithiothreitol is about 5 days at 4 °C. The purified enzyme completely lost its activity on
freezing and thawing.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 4.
A, affinity purification of the
recombinant enzyme. The E. coli expressing the reductase
cDNA was grown (250-ml culture) in the presence of IPTG as
described under "Experimental Procedures." Six h after the
addition of IPTG, the cells were harvested by centrifugation and stored
frozen at 20 °C overnight. The cells were thawed, and the
recombinant enzyme was extracted (7 ml, 875 milliunits total) from the
cells and then purified by affinity chromatography (2.5 ml
Ni2+-nitrilotriacetic acid matrix) as described under
"Experimental Procedures." FT, flow-through (7 ml); Wash 1, 25 ml of buffer containing 5 mM imidazole; Wash 2, 15 ml of buffer
containing 60 mM imidazole; Elute 1,
15 ml of buffer containing 0.3 M imidazole;
Elute 2, 10 ml of buffer containing 1.0 M imidazole. The total activity of reductase present in
each fraction is shown. B, SDS-PAGE analysis of the column
fractions. Twelve µl of each fraction was used for electrophoresis.
Lane 1, flow-through; lane
2, wash 1 (5 mM imidazole); lane
3, wash 2 (60 mM imidazole); lane
4, elute 1 (0.3 M imidazole); lane
5, elute 2 (1.0 M imidazole); lane
6, crude E. coli cell extract that was loaded to
the column; lane 7, partially purified guinea pig
liver peroxisomal enoyl-CoA reductase (solubilized fraction, Table II);
lane 8, protein molecular weight standards as
indicated.
|
|
The human recombinant His-tagged enzyme was also similarly expressed
and affinity-purified. The properties of the human reductase are
similar to those described for the guinea pig recombinant enzyme (data
not shown).
Properties of the Recombinant Reductase--
The properties of
the guinea pig recombinant reductase are similar to those of the
peroxisomal enzyme as evidenced by its specificity toward using NADPH
as the coenzyme and inhibition by the thiol-reactive reagent,
N-ethylmaleimide (Table III).
In a spectrophotometric assay, the recombinant enzyme, like the
peroxisomal enzyme (Table I), was found not to use NADH as the coenzyme
(data not shown). Unlike liver peroxisomes, the purified recombinant enzyme did not have any 2,4-dienoyl-CoA reductase activity (Table III).
This indicates that the peroxisomal 2,4-dienoyl-CoA reductase is an
enzyme distinct from the peroxisomal enoyl-CoA reductase whose cDNA
we cloned. Both the recombinant and liver peroxisomal enzymes are
inhibited by higher concentrations (>50 µM) of
decenoyl-CoA (data not shown). The apparent Km
values for decenoyl-CoA were 11 and 18 µM for the
peroxisomal and the recombinant enzymes, respectively. The
corresponding Km values for NADPH were 38 and 53 µM. The substrate specificity of both the peroxisomal and
the recombinant enzymes toward different enoyl-CoAs is similar (except
for 6:1) with maximum activity against 10:1 CoA, and the specificity is
different from that of guinea pig liver microsomal reductase (Fig.
5). As reported previously (26), it is
also seen here that the microsomal reductase has the highest activity with 2-hexenoyl-CoA (Fig. 5). The relatively higher activity of the
peroxisomal enzyme with 6:1 CoA compared with the recombinant enzyme is
probably due to microsomal contamination (~10%) of the peroxisome
preparation.
View this table:
[in this window]
[in a new window]
|
Table III
Inhibition and specificity of peroxisomal and recombinant enzymes
The assay mixtures contained phosphate buffer (50 mM, pH
7.4), S-[4-3H]NADPH (70 µM, 8000 dpm/nmol), peroxisomes (10-40 µg of protein) or purified recombinant
enzyme (0.5-2.0 µg of protein), and acyl-CoAs (30 µM)
as indicated. Bovine serum albumin (2 mg/ml) was also included for the
2-enoyl reductase assay. For the N-ethylmaleimide (NEM)
inhibition studies, the enzyme in 0.1 M phosphate buffer
was preincubated with N-ethylmaleimide (1.0 mM)
for 5 min at 37 °C, and aliquots were used for the assay. The
results presented are the average of four radiometric assays.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 5.
Chain length specificity of guinea pig liver
microsomal (MS), peroxisomal (PX),
and the purified recombinant enzyme (RE). The
rate of reduction of different enoyl-CoAs (40 µM) having
different chain lengths by S-[4-3H]NADPH (70 µM) catalyzed by the reductase from different sources was
determined radiometrically as described under "Experimental
Procedures." The results are presented as the percentage of maximum
activity, which was 10.5 milliunits/mg of protein for microsomes with
6:1 CoA, 4.1 milliunits/mg of protein for peroxisomes with 10:1 CoA,
and 860 milliunits/mg of protein for the purified recombinant reductase
with 10:1 CoA.
|
|
Identification of the Enzymatic Reaction Product--
The
product of the reaction between 2-decenoyl-CoA and
4-[3H]NADPH, catalyzed either by peroxisomes or purified
recombinant enzyme, was identified as [3H]decanoyl-CoA.
This was done by converting the labeled reaction product to methyl
ester, which was then cochromatographed with methyl 2-decenoate and
methyl decanoate on a silver nitrate-coated TLC plate (see
"Experimental Procedures"). All of the radioactivity migrated with
the faster moving methyl decanoate (Rf = 0.64) and
not with the methyl decenoate (Rf = 0.56), indicating that the double bond of the 2-decenoyl-CoA is reduced by
NADPH to a saturated acyl-CoA.
Peroxisomal Localization of the Cloned Reductase--
The
purification of the enzyme from isolated guinea pig liver peroxisomes
and the presence of a PTS-1 in the amino acid sequence of the enzyme
indicate that the cloned reductase is a peroxisomal enzyme. This is
confirmed by Western blot analysis using a monoclonal antibody raised
against the purified enzyme. Although, in addition to peroxisomal
activity, enoyl-CoA reductase activity is also present in mitochondria
and at a higher concentration in the ER (microsomes), the monoclonal
antibody raised against the partially purified enzyme interacted
specifically with the peroxisomal fraction (Fig.
6). The weak positive signal seen in
mitochondrial and microsomal fractions is probably due to the presence
of contaminating peroxisomes in these fractions, as evidenced by the
activity of peroxisome membrane-specific DHAP acyltransferase in
these fractions (Fig. 6). The specificity of the antibody used for the
cloned enzyme is also seen in Fig. 6 by its interaction with the
recombinant reductase. As indicated above, because of the presence of
additional amino acids, including the His tag at the N terminus of the
recombinant enzyme, the molecular mass of the recombinant enzyme is
greater (by about 4 kDa) than that of the native enzyme.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 6.
Western blot analysis of the distribution of
the cloned enoyl-CoA reductase in guinea pig liver subcellular
fractions. The subcellular fractionations, assays of different
enzymes, and Western blotting were done as described under
"Experimental Procedures." The distribution of the enoyl-CoA
reductase activity (top panel) in the major
subcellular fractions and Western blot analysis (bottom
panel) of the same fractions are shown along with the
distribution of organelle-marker enzymes. S-1, postnuclear
supernatant; MT, mitochondria (marker enzyme,
succinate-cytochrome c reductase); PX,
peroxisomes (marker enzyme, DHAP acyltransferase measured at pH 5.5);
MS, microsomes (marker enzyme, ER-specific NADPH-cytochrome
c reductase); Cyt, cytosol; rRed,
recombinant His-tagged enoyl-CoA reductase; STD, protein
molecular mass standard (42-kDa protein band is shown by the
arrowhead). The specific activities of different enzymes in
each subcellular fraction are shown (top four
panels). The amounts of protein used in the SDS-PAGE for the
Western analysis as shown in the bottom panel
were 1.5 µg for postnuclear supernatant; 0.2 µg each for
mitochondria, peroxisomes, and microsomes; and 0.03 µg for the
purified (Fig. 4) recombinant reductase.
|
|
Northern Blot Analysis--
When a mouse multitissue RNA blot
was hybridized with the 32P-labeled mouse DNA probe as
described above, a single radioactive band of ~1.3 kb was seen with
greatest intensities in liver and kidney and at lower levels in heart,
skeletal muscle, and other tissues (Fig.
7). Hybridization of a guinea pig tissue
RNA blot with the same 32P-probe showed a single transcript
of 1.5 kb present not only in liver and kidney but also in other
tissues in much lower concentrations (data not shown).

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 7.
Northern blot analysis. The mouse
multitissue poly(A)+ RNA (2 µg each) blot
(CLONTECH) was hybridized with a
32P-labeled reductase cDNA probe, washed, and
autoradiographed as described under "Experimental
Procedures." The upper panel shows the
autoradiogram after overnight exposure, and the lower
panel shows the autoradiogram of the same blot (1.3-kilobase
region) after longer exposure (5 days) to the x-ray film. The
mobilities of the size markers and the tissues used (Muscle
represents skeletal muscle) are shown.
|
|
 |
DISCUSSION |
The induction of the active 2-enoyl-CoA reductase when the
cDNAs were expressed in E. coli and the similarity of
the properties and specificity of the purified recombinant enzyme with
those of the peroxisomal enzyme, but not with the microsomal reductase, show that the cloned cDNAs encode a peroxisomal
trans-2-enoyl-CoA reductase. The presence of the PTS-1 in
the protein sequences and Western analysis of its subcellular
distribution (Fig. 6) corroborate the peroxisomal location of the
reductase. These results also confirm the report by Horie et
al. (6), which provided good evidence for the presence of an
enoyl-CoA reductase in rat liver peroxisomes. The reaction catalyzed by
this reductase is shown below (Scheme 1).
As indicated above, the putative amino acid sequences of the
reductase (Fig. 3) have high homology to a large number of pyridine nucleotide-linked dehydrogenases. These polypeptide sequences seem to
belong to the recently described "short chain acyl
dehydrogenase/reductase" family (27). For example, the N-terminal
part of the consensus sequence of the reductase has the same
NAD(P)H-binding motif, GXXXGXG, at amino acid
residues 25-31 (Fig. 3). Similarly, the YX3-7K
motif shown to be present in the catalytic center of such
dehydrogenases is also present in the enoyl-CoA reductase at residues
179-183 (178-182 for the guinea pig enzyme). The amino acid sequences
of the enoyl-CoA reductase (Fig. 3) have hydrophobic stretches
(e.g. from residue 153 to 162 and from 242 to 251), but none
of them meet the criteria for a membrane-spanning
-helical structure. Interestingly, there are two conserved
N-glycosylation motifs (NLT) at positions 131 and 180 (179 for the guinea pig) of the amino acid sequences. Although to date no
peroxisomal proteins have been shown to be
N-glycosylated (28), recently Elgersma et al.
provided evidence that Pex 15P, an S. cerevisiae
peroxisomal membrane protein, is O-glycosylated
(29).
Among the mammalian dehydrogenases, the enoyl-CoA reductase has high
homology to both mitochondrial (31% identity, 51% similarity) and
peroxisomal (31% identity, 49% similarity) 2,4-dienoyl-CoA reductase
(30, 31). The peroxisomal enoyl-CoA reductases also have homology to
the bacterial enoyl-ACP reductases that catalyze the same reaction
(22% identity and 50% similarity extending throughout the protein
sequence of the E. coli enzyme). Surprisingly, the reductase
sequences (Fig. 3) have only very limited homology to the enoyl
reductase domain of the multifunctional mammalian fatty acid synthase
(32, 33). This indicates that the enoyl reductases described here
belong to a new family of enzymes and may have counterparts in the ER
and mitochondria of mammalian cells. Therefore, the availability of
these cDNA clones will aid in the discovery of other cellular
isoenzymes, and the active recombinant enzyme will facilitate studies
into the structure of the enzyme and the molecular details of the
catalytic mechanism for the reduction of the double bond.
As discussed above, one rat cDNA recently submitted to
GenBankTM (AF021854 and AF099742) from two different
laboratories has very high homology to the cloned cDNAs reported
here, indicating that it is most probably the rat counterpart of
peroxisomal enoyl-CoA reductase. Although AF021854 was tentatively
designated as coding for 2,4-dienoyl-CoA reductase, we did not find any
such activity in the recombinant guinea pig enzyme. While this
manuscript was in preparation, the details of cloning of the AF099742 were described by Zhang and Underwood (34). These authors isolated the
clone from fasted rat liver cDNA library prepared by "suppression subtractive hybridization." Although the enzyme it coded was not identified, they also pointed out the homology of the sequence to short
chain acyl dehydrogenase/reductase family and the presence of PTS-1 in
the putative polypeptide. Consistent with our results, transcript
levels were found to be highest in rat liver and kidney, and it has
been also shown that the liver transcript level is increased when the
rats are fasted for 48 h. Sequence homology, as shown in Fig. 3,
strongly suggests that this cDNA encodes the rat peroxisomal
2-enoyl-CoA reductase.
Although the partially purified peroxisomal enzyme seemed to be
about 40-60% pure, it had a much lower specific activity (75 milliunits/mg of protein by radiometric assay) than the purified recombinant enzyme (600-750 milliunits/mg of protein). This is probably because the enzyme became very labile after the detergent solubilization but a significant fraction of the partially denatured enzyme still was capable of binding to the NADP+ affinity
matrix. The purified recombinant enzyme had up to 2.0 units/mg of
protein activity by the spectrophotometric assay, which is ~200 times
the specific activity of the liver peroxisomal reductase. The
expression of an active recombinant enzyme in E. coli shows
that post-translational modifications (e.g. glycosylation) are not necessary for enzyme activity.
The substrate specificity of the enzyme shows that it may be termed a
medium chain enoyl-CoA reductase, with specificity similar to that of
mitochondrial and microsomal reductases. However, the longer chain
enoyl-CoAs (14:1 and 16:1) are also good substrates for both the
microsomal and the peroxisomal enzymes (Fig. 7), indicating that this
enzyme may have a similar function in both of these organelles. Horie
et al. (6) showed that in peroxisomes, octanoyl-CoA is
chain-elongated to form dodecanoyl-CoA, and recently, Hayashi and Sato
(35) demonstrated that in rat liver peroxisomes dodecanoyl-CoA was
chain-elongated to form palmitoyl-CoA, which was reduced to hexadecanol
by the NADPH-linked peroxisomal acyl-CoA reductase (36). These results
show that fatty acid chain elongation in peroxisomes can be
demonstrated in vitro. The physiological importance of the
peroxisomal chain elongation system, however, is not clear. Although
the specific activity of the peroxisomal enoyl-CoA reductase, the key
enzyme for the fatty acid chain elongation system, is similar to that
of the ER enzyme, the total activity of cellular ER reductase is much
more than the peroxisomal enzyme, because the ER contains about 10 times more protein than peroxisomes per cell (37). Therefore, it seems
that the ER is the main cellular site for chain elongation of fatty acids.
There is also a dilemma concerning the peroxisomal and also
mitochondrial elongation systems because a highly active fatty acid
-oxidation system is also present in the these organelles. It is not
clear how these two opposing metabolic pathways could be regulated
without compartmentalization. It is possible that the peroxisomal
enoyl-CoA reductase may have some functions other than participating in
the fatty acid chain elongation system. For example, this reductase may
be involved in the reduction of cis-double bonds at
even-numbered carbons of unsaturated fatty acids. It has been shown
that in mitochondria these fatty acids are mainly metabolized via their
conversion to 2,4-dienoyl-CoA followed by reduction (NADPH) to
3-enoyl-CoA, which is then isomerized to trans-2-enoyl-CoA
(38). trans-2-Enoyl-CoA is either further metabolized by
-oxidation or is reduced by NADPH-linked 2-enoyl-CoA reductase. The
presence of 2,4-dienoyl-CoA reductase,
3,
2-enoyl-CoA isomerase (38), and also,
as shown here, enoyl-CoA reductase in peroxisomes indicates that a
similar conversion of cis-double bonds may occur in
peroxisomes. Recent findings show that unsaturated fatty acids having
double bond(s) at the odd-numbered carbon atoms are also not oxidized
directly in the
-oxidation pathway but are converted to medium chain
2-enoyl-CoAs via a reductive pathway (39, 40). The key enzyme for such
conversion, i.e.
3,5,
2,4-dienoyl-CoA isomerase, has been
shown to be present in both liver mitochondria and peroxisomes (41).
Because medium chain acyl-CoAs are not the substrates for peroxisomal
-oxidation, the peroxisomal enoyl-CoA reductase could catalyze the
reduction of the medium chain enoyl-CoAs formed via these reductive
pathways to the saturated acyl-CoAs, which may then be converted to the
carnitine derivatives and exported to mitochondria for oxidation and
energy production. This pathway is probably physiologically important
for the complete oxidation of unsaturated fatty acids in liver,
especially when the metabolism is switched from utilizing glucose to
utilizing fatty acids in conditions such as starvation or an acute
diabetic state (42, 43). Therefore, the present report of cloning the enoyl-CoA reductase cDNAs will not only facilitate cloning of the
cDNAs of other cellular isoforms of this key enzyme of fatty acid
metabolism and study of the structure-function relationship of the
enzyme but also will be useful for understanding the mechanism of
regulation of fatty acid metabolism in different physiological and
pathological conditions.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Shuichi Horie for the
generous gift of different 2-enoic acids and Karen Hajra for invaluable
assistance and editorial advice in the preparation of the manuscript.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant NS 15747.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF232009, AF232010, and AF232011.
To whom correspondence should be addressed: Neuroscience
Laboratory, University of Michigan, 1103 E. Huron St., Ann Arbor, MI
48104-1687. Tel.: 734-763-4368; Fax: 734-936-2690; E-mail: akhajra@umich.edu.
Published, JBC Papers in Press, May 11, 2000, DOI 10.1074/jbc.M001168200
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic
reticulum;
DHAP, dihydroxyacetone phosphate;
IPTG, isopropyl
-D-thiogalactopyranoside;
EST, expressed sequence tag;
TES, 2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic
acid;
PAGE, polyacrylamide gel electrophoresis;
kb, kilobase pair(s);
PTS-1, type 1 peroxisome-targeting signal.
 |
REFERENCES |
| 1.
|
Cinti, D. L.,
Cook, L.,
Nagi, M. N.,
and Suneja, S. K.
(1992)
Progr. Lipid Res.
31,
1-51
|
| 2.
|
Sprecher, H.,
Luthria, D. L.,
Mohammed, B. S.,
and Baykousheva, S. P.
(1995)
J. Lipid Res.
36,
2471-2477
|
| 3.
|
Seubert, W.,
and Podack, E. R.
(1973)
Mol. Cell. Biochem.
1,
29-40
|
| 4.
|
Cvetanovic, M.,
Moreno de la Garza, M.,
Dommes, V.,
and Kunau, W. H.
(1985)
Biochem. J.
227,
9-56
|
| 5.
|
Nagi, M. N.,
Cook, L.,
Ghesquier, D.,
and Cinti, D. L.
(1986)
Arch. Biochem. Biophys.
248,
408-418
|
| 6.
|
Horie, S.,
Suzuki, T.,
and Suga, T.
(1989)
Arch. Biochem. Biophys.
274,
64-73
|
| 7.
|
Datta, S. C.,
Ghosh, M. K.,
and Hajra, A. K.
(1990)
J. Biol. Chem.
265,
8268-8274
|
| 8.
|
Lauer, W. M.,
Gensler, W. J.,
and Miller, E.
(1941)
J. Am. Chem. Soc.
63,
1153-1155
|
| 9.
|
Thomason, S. C.,
and Kubler, D. G.
(1968)
J. Chem. Educ.
45,
546-547
|
| 10.
|
Hajra, A. K.,
and Bishop, J. E.
(1986)
Methods Enzymol.
122,
50-53
|
| 11.
|
Stadtman, E. R.
(1957)
Methods Enzymol.
3,
931-941
|
| 12.
|
Ellman, G. L.
(1959)
Arch. Biochem. Biophys.
82,
70-77
|
| 13.
|
Nada, M. A.,
Roe, C. R.,
and Schulz, H.
(1992)
Anal. Biochem.
201,
62-67
|
| 14.
|
Hajra, A. K.,
Larkins, L. K.,
and Reddy, J. K.
(1998)
in
Cell: A Laboratory Manual
(Spector, D. L.
, Leinwand, L.
, and Goldman, R., eds)
, pp. 40.1-40.12, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 15.
|
Broustas, C. G.,
and Hajra, A. K.
(1995)
J. Neurochem.
64,
2345-2353
|
| 16.
|
Bensadoun, A.,
and Weinstein, D.
(1976)
Anal. Biochem.
70,
241-250
|
| 17.
|
Radin, N. S.,
Hajra, A. K.,
and Akahori, Y.
(1960)
J. Lipid Res.
1,
250-251
|
| 18.
|
Wood, R.,
and Lee, T.
(1981)
J. Biol. Chem.
256,
12379-12386
|
| 19.
|
Wright, R. S.
(1971)
J. Chromatogr.
59,
220-221
|
| 20.
|
Matsudaira, P.
(1990)
Methods Enzymol.
182,
602-613
|
| 21.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, pp. 7.19-7.52, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 22.
|
Broustas, C. G.,
Larkins, L. K.,
Uhler, M. D.,
and Hajra, A. K.
(1996)
J. Biol. Chem.
271,
10470-10476
|
| 23.
|
Kirkman, H. N.,
and Gaetani, G. F.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
4343-4347
|
| 24.
|
Kozak, M.
(1992)
Annu. Rev. Cell Biol.
8,
197-225
|
| 25.
|
Subramani, S.
(1998)
Physiol. Rev.
78,
171-188
|
| 26.
|
Podack, E. R,
Lakomek, M.,
Saathoff, G.,
and Seubert, W.
(1974)
Eur. J. Biochem.
45,
13-23
|
| 27.
|
Jornvall, H.,
Persson, B.,
Krook, M.,
Atrian, S.,
Gonzalez-Duarte, R.,
Jeffery, J.,
and Ghosh, D.
(1995)
Biochemistry
34,
6003-6013
|
| 28.
|
Volkl, A.,
and Lazarow, P. B.
(1982)
Ann. N. Y. Acad. Sci.
386,
504-505
|
| 29.
|
Elgersma, Y.,
Kwast, L.,
van den Berg, M.,
Snyder, W. B.,
Distel, B.,
Subramani, S.,
and Tabak, H. F.
(1997)
EMBO J.
16,
7326-7341
|
| 30.
|
Fransen, M.,
Van Veldhoven, P. P.,
and Subramani, S.
(1999)
Biochem. J.
340,
561-568
|
| 31.
|
Geisbrecht, B. V.,
Liang, X.,
Morrell, J. C.,
Schulz, H.,
and Gould, S. J.
(1999)
J. Biol. Chem.
274,
25814-25820
|
| 32.
|
Witkowski, A.,
Rangan, V. S.,
Randhawa, Z. I.,
Amy, C. M.,
and Smith, S.
(1991)
Eur. J. Biochem.
198,
571-579
|
| 33.
|
Chirala, S. S.,
Huang, W. Y.,
Jayakumar, A.,
Sakai, K.,
and Wakil, SJ
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
5588-5893
|
| 34.
|
Zhang, J.,
and Underwood, L. E.
(1999)
Biochim. Biophys. Acta
1435,
184-190
|
| 35.
|
Hayashi, H.,
and Sato, A.
(1997)
Biochim. Biophys. Acta
1346,
38-44
|
| 36.
|
Burdett, K.,
Larkins, L. K.,
Das, A. K.,
and Hajra, A. K.
(1991)
J. Biol. Chem.
266,
12201-12206
|
| 37.
|
De Duve, C.
(1971)
J. Cell Biol.
50,
20d-55d
|
| 38.
|
Kunau, W. H.,
Dommes, V.,
and Schulz, H.
(1995)
Progr. Lipid Res.
34,
267-342
|
| 39.
|
Tserng, K. Y.,
Jin, S. J.,
and Chen, L. S.
(1996)
Biochem. J.
313,
581-588
|
| 40.
|
Shoukry, K.,
and Schulz, H.
(1998)
J. Biol. Chem.
273,
6892-6899
|
| 41.
|
He, X. Y.,
Shoukry, K.,
Chu, C.,
Yang, J.,
Sprecher, H.,
and Schulz, H.
(1995)
Biochem. Biophys. Res. Commun.
215,
15-22
|
| 42.
|
Kersten, S.,
Seydoux, J.,
Peters, J. M.,
Gonzalez, F. J.,
Desvergne, B.,
and Wahli, W.
(1999)
J. Clin. Invest.
103,
1489-1498
|
| 43.
|
Kroetz, D. L.,
Yook, P.,
Costet, P.,
Bianchi, P.,
and Pineau, T.
(1998)
J. Biol. Chem.
273,
31581-31589
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Bye, M. A. Hoydal, D. Catalucci, M. Langaas, O. J. Kemi, V. Beisvag, L. G. Koch, S. L. Britton, O. Ellingsen, and U. Wisloff
Gene expression profiling of skeletal muscle in exercise-trained and sedentary rats with inborn high and low VO2max
Physiol Genomics,
November 1, 2008;
35(3):
213 - 221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gloerich, D. M. van den Brink, J. P. N. Ruiter, N. van Vlies, F. M. Vaz, R. J. A. Wanders, and S. Ferdinandusse
Metabolism of phytol to phytanic acid in the mouse, and the role of PPAR{alpha} in its regulation
J. Lipid Res.,
January 1, 2007;
48(1):
77 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. van den Brink, J. N. I. van Miert, G. Dacremont, J.-F. Rontani, and R. J. A. Wanders
Characterization of the Final Step in the Conversion of Phytol into Phytanic Acid
J. Biol. Chem.,
July 22, 2005;
280(29):
26838 - 26844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hoffmeister, M. Piotrowski, U. Nowitzki, and W. Martin
Mitochondrial trans-2-Enoyl-CoA Reductase of Wax Ester Fermentation from Euglena gracilis Defines a New Family of Enzymes Involved in Lipid Synthesis
J. Biol. Che |